PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7128520

[Irritable colon syndrome].

H Bosseckert
View original source ↗Export metadata ↓

Abstract

The irritable bowel syndrome is one of the most frequent diseases which could be observed in a gastroenterologic practice. The knowledge of its symptoms allows a preliminary diagnosis (working diagnosis) which must be secured by an extensive exclusion diagnosis if there is no improvement of the complaints within 2-3 weeks or if the symptoms like blood in the faeces, increasing fatigue, elevated sedimentation rate and so on will be developed. The foundation of the treatment are a conversation in detail with the patient, a high residue diet, sufficient bodily conditioning, massage of the large bowel, and gifts of anticholinergics.

Explore related subjects

Colonic Diseases, FunctionalFemaleGastrointestinal MotilityHumansMalePhysician-Patient RelationsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Bosseckert. 1982. [Irritable colon syndrome].. https://pubmed.ncbi.nlm.nih.gov/7128520/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.

Functional digestive disorders constitute one of the main causes of consultation in gastroenterology and primary health care. Is still unclear whether therapy has to be aimed to the gut, to the neural pathways controlling bowel motility and perception, or to the processing mechanisms of symptoms and disease behaviour. It is conceivable that in the next future better understanding of functional bowel disorders pathophysiology will help us to tailor treatment for different patients. At the moment, subclassification of the diverse patterns of symptomatology allows to adjust new treatments for irritable bowel syndrome (IBS) according to the clinical predominance for each patient. The knowledge of motor and sensorial response to different stimuli in IBS patients and the pathways to the central nervous system is an important source of information for the development of new molecules. Fiber-enriched diet is frequently given for constipation-predominant IBS. Loperamide, antispasmodic drugs and tricyclic antidepressants are nowadays the basis for pharmacological treatment of diarrhea- predominant IBS. The scientific evidence supporting this therapeutical approach is however limited. Visceral analgesics and serotonin agonists and antagonists may play an important therapeutical role in the near future. However, it is not likely that one single treatment will help every functional bowel disorder patient and many of them will need a more complex approach with a multidisciplinary therapy (diet, psychotherapy, medications).

Colonic Diseases, Functional↗
PubMed2005

Hypnotherapy for functional gastrointestinal disorders.

About 20% of people in the UK have functional gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia. These conditions account for about 4% of GP consultations and 50% of gastroenterologists' workload. Forsome, the symptoms affect quality of life and ability to work. Drug treatment aimed at relieving symptoms is often ineffective. Other options include psychological treatments such as cognitive behavioural therapy, brief psychotherapy and gut-directed hypnotherapy. Here we discuss whether hypnotherapy has a role in the treatment of patients with irritable bowel syndrome or functional dyspepsia.

Colonic Diseases, Functional↗